A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 4074
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : QALYs
Long Form : quality-adjusted life years
No. Year Title Co-occurring Abbreviation
2019 "Proximal Row Carpectomy versus Four-Corner Arthrodesis for the Treatment of SLAC/SNAC Wrist: A Cost-Utility Analysis". PRC, SLAC, SNAC
2019 5-year versus risk-category-specific screening intervals for cardiovascular disease prevention: a cohort study. ASCVD
2019 A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: clinical outcomes and cost-effectiveness analysis. BGC
2019 A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia. DOACs, IPC, LMWH, VTE
2019 A cost effectiveness analysis of maintenance cognitive stimulation therapy (MCST) for people with dementia: examining the influence of cognitive ability and living arrangements. MCST
2019 A Cost-Effectiveness Analysis of a Randomized Control Trial of a Tailored, Multifactorial Program to Prevent Falls Among the Community-Dwelling Elderly. ED, ICER, SPPB
2019 A Cost-Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First-Line Intermediate- to Poor-Risk Advanced Renal Cell Carcinoma. ICER, RCC
2019 A cost-effectiveness analysis of the use of safety-engineered syringes in reducing HBV, HCV, and HIV burden in Egypt. CS, SS
2019 A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain. ---
10  2019 A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer. ICUR, LVOS, MFFR
11  2019 A cost-utility analysis of decompressive hemicraniectomy versus medical treatment in the management of space-occupying brain oedema post middle cerebral artery infarction. NICE
12  2019 A Cost-utility Analysis of Percutaneous Endoscopic Lumbar Discectomy for L5-S1 Lumbar Disc Herniation: Transforaminal versus Interlaminar. CUA, CUA, ICERs, JOA, LDH, ODI, PEID, PELD, PETD, VAS
13  2019 A decision analysis comparing 3 active surveillance protocols for the treatment of patients with low-risk prostate cancer. AS
14  2019 A dynamic, modifiable model for estimating cost-effectiveness of smoking cessation interventions in pregnancy: application to an RCT of self-help delivered by text message. ESIP, NHS
15  2019 A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT. EMQ-p, NIHR, TBIs
16  2019 A guided and unguided internet- and mobile-based intervention for chronic pain: health economic evaluation alongside a randomised controlled trial. CG
17  2019 A health utility assessment of trapeziectomy with ligament reconstruction and tendon interposition for thumb trapeziometacarpal osteoarthritis. LRTI
18  2019 An Economic Analysis of Medical and Surgical Management of Aortopathy Associated with Bicuspid Aortic Valve. ABAV, AoS, WW, WW
19  2019 An economic evaluation of a telephone outcall intervention for informal carers of cancer patients in Australia: An assessment of costs and quality-adjusted-life-years. ICER, RCT, RUQ
20  2019 An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care. ICER, SSRI, TCA
21  2019 Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. ---
22  2019 Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis. cDMARDs, ICER, TIMs
23  2019 Association of current and past opioid use disorders with health-related quality of life and employment among US adults. NESARC III, OUD, PCS
24  2019 Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine. COPD
25  2019 Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting. MI, MVC, UAS
26  2019 Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England. HPV
27  2019 Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT. AE, CBT, CI, CRS, EQ-5D-5L, FOCUS, ITT, NIHR, PANSS, TAU
28  2019 Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma. ICER, IO, OS, PFS, PLS, PSMs
29  2019 Comparative cost-effectiveness analysis of the subacromial spacer for irreparable and massive rotator cuff tears. ICER, IRCT, RCR
30  2019 Comparative Cost-utility Analysis Between Aprepitant- and Fosaprepitant-containing Regimens To Prevent Chemotherapy-induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Japan. APR, FosAPR, ICER
31  2019 Comparative effectiveness analysis of Pipeline device versus coiling in unruptured aneurysms smaller than 10 mm. PED, SAC
32  2019 Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer. MIBC, RC, TMT
33  2019 Comparative Effectiveness of Endovascular Thrombectomy in Elderly Stroke Patients. EVT, IVT
34  2019 Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria. cUTI
35  2019 Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey. CKD, CUA, MAUIs
36  2019 Coronary computed tomography angiography vs. myocardial single photon emission computed tomography in patients with intermediate risk chest pain: a randomized clinical trial for cost-effectiveness comparison based on real-world cost. CCTA, ICA, SPECT
37  2019 Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology. HPV, ICER
38  2019 Cost effectiveness and quality of life analysis of extracorporeal cardiopulmonary resuscitation (ECPR) for refractory cardiac arrest. CPC, ECMO, ECPR, ICER, ICERs, PSA
39  2019 Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma. mMCC, SC, TE, TN
40  2019 Cost Effectiveness of Endoscopic Resection vs Transanal Resection of Complex Benign Rectal Polyps. ER, TAMIS, TEM
41  2019 Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada. T2D
42  2019 Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease. ICER, SOC, VA, VF, VN
43  2019 Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa. CEA, CHW, DCAS, ICER, RCTs, T2DM
44  2019 Cost-effectiveness analysis of a placebo-controlled randomized trial evaluating the effectiveness of arthroscopic subacromial decompression in patients with subacromial shoulder pain. NHS, SE
45  2019 Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. JIA
46  2019 Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer. PD, PFS
47  2019 Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis. GB, ICERs, ILI, NASH, SG
48  2019 Cost-Effectiveness Analysis of Combined Dual Motor Nerve Transfers versus Alternative Surgical and Nonsurgical Management Strategies to Restore Shoulder Function Following Upper Brachial Plexus Injury. CDNT, GA, UBPI
49  2019 Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer. CRS, HIPEC, ICER, LYs, mCRC, PC, PSA, WTP
50  2019 Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy. DCV, GT, LDV, PSA, RBV, SOF
51  2019 Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes. CDM, PSA
52  2019 Cost-Effectiveness Analysis of Descemet's Membrane Endothelial Keratoplasty Versus Descemet's Stripping Endothelial Keratoplasty in the United States. DMEK, DSAEK
53  2019 Cost-effectiveness analysis of English memory assessment services 2years after first consultation for patients with dementia. HRQL, MAS
54  2019 Cost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China. ICER, NSCLC
55  2019 Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China. CERs, HBsAg, HBV
56  2019 Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan. JPY, uHCC
57  2019 Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). ARV, cART, CEPT, CI
58  2019 Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer. ICERs, LET, OS, PAL, PFS, RIB
59  2019 Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States. ICERs, LYs, TH, THP
60  2019 Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention. ICER, PCI
61  2019 Cost-effectiveness analysis of postpolypectomy colonoscopy surveillance using Japanese data. program 1
62  2019 Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. MODY, MPS, QOL
63  2019 Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective. AS, BASFI, IL
64  2019 Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States. ABL, ACTIVE, ALN, DES, ICER, PBO, PMO, TPTD
65  2019 Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. IOP, OAG, SOC, TBS, VF
66  2019 Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland. DAAs, HCV, ICER
67  2019 Cost-effectiveness analysis of telephone cognitive-behaviour therapy for adolescents with obsessive-compulsive disorder. NIHR, NIMH, OCD, TCBT
68  2019 Cost-Effectiveness Analysis of Trauma-Focused Cognitive Behavioral Therapy: A Randomized Control Trial among Norwegian Youth. HRQoL, TAU, TF-CBT
69  2019 Cost-effectiveness analysis of utidelone plus capecitabine for metastatic breast cancer in China. ICER, MBC, WTP
70  2019 Cost-effectiveness and cost-utility analysis of outpatient follow-up frequency in relation to three-year mortality in discharged patients with bipolar disorder. BD
71  2019 Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation. AIMS, HIV, ICER, TAU
72  2019 Cost-effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-risk Persons at Age 45 Years Instead of 50 Years. CRC
73  2019 Cost-effectiveness and quality of life of a diet intervention postpartum: 2-year results from a randomized controlled trial. QOL
74  2019 Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme. ECG, NNS
75  2019 Cost-Effectiveness of a Team-Based Integrative Medicine Approach to the Treatment of Back Pain. BOP, BWH, CLBP, ICER, OCC, RDQ
76  2019 Cost-Effectiveness of Adding Androgen Deprivation Therapy to Radiation Therapy for Men with Advanced Prostate Cancer from a U.S. Payer's Perspective. ADT, ICER, SEER
77  2019 Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China. EGFR, HR, ICER, NSCLC, OS, PC, TKI
78  2019 Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China. ALK, CNS, ICER, NSCLC, PF, PP, WTP
79  2019 Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States. RMS
80  2019 Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live. RZV, ZONA, ZVL
81  2019 Cost-effectiveness of an integrated 'fast track' rehabilitation service for multi-trauma patients: A non-randomized clinical trial in the Netherlands. Fast Track, FIM, ICERs
82  2019 Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study). AM, ICUR, WTP
83  2019 Cost-effectiveness of antiosteoporosis strategies for postmenopausal women with osteoporosis in China. ICERs
84  2019 Cost-effectiveness of bedaquiline or delamanid plus background regimen for multidrug-resistant tuberculosis in a high-income intermediate burden city of China. BR, D-BR, ICER, TB
85  2019 Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France. ESME, FCCC, ICER, OS, PFS
86  2019 Cost-effectiveness of breast cancer screening programme for women in rural China. ICER
87  2019 Cost-Effectiveness of Bridging Anticoagulation Among Patients with Nonvalvular Atrial Fibrillation. ---
88  2019 Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events. CANTOS, hs-CRP, MI
89  2019 Cost-Effectiveness of Cervical Epidural Steroid Injections: A 3-Month Pilot Study. EQ-5D, ESIs, ICER, QOL
90  2019 Cost-effectiveness of combination disease-modifying antirheumatics vs. tumour necrosis factor inhibitors in active rheumatoid arthritis: TACIT trial. cDMARDS, HAQ, RA, TNFis
91  2019 Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland. CSII, MDI
92  2019 Cost-effectiveness of docetaxel in high-volume hormone-sensitive metastatic prostate cancer. ADT, CRPC, HSPC, ICER
93  2019 Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease. FC, IBD, ICER
94  2019 Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study. CVD, ICERs, NHANES, SNAP
95  2019 Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes. YOLS
96  2019 Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies. DMO, ETDRS, FAc, ICERs, NHS
97  2019 Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy. EOC, HIPEC, ICER, ICS, NACT
98  2019 Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. ICERs, mCRC, MSI-H
99  2019 Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan. GC, GIO, ICER, YAM
100  2019 Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes. T2DM